Spironolactone Improved Children With Gene Mutations Related to NCOR
Clinical trial NCT06678685 · RECRUITING
Trial details
- NCT number
- NCT06678685
- Sponsor
- Qilu Hospital of Shandong University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2026-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.